Cutaneous manifestation of silicone dissemination from a PIP implant--a case for prophylactic explantation?

Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2011 Vol.64(8) p. e208-9

Cawrse NH, Pickford MA

관련 도메인

Abstract

The recent withdrawal of PIP (Poly Implant Prosthese, France) implants for breast augmentation enforced by the Medicines and Healthcare products Regulatory Agency (MHRA) on 31st March 2010 has ignited speculation into possible side effects relating to an unauthorized gel fill content. Local and migratory silicone granulomata and regional lymphadenopathy are well reported in the literature. Gel bleed from high cohesive gel implants with similar effect is also well known. However dissemination to sites distant from the breast manifest as cutaneous abnormalities in a patient implanted with a PIP product raises concern. We report such a case.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 2
시술 breast augmentation 유방성형술 dict 1
합병증 lymphadenopathy scispacy 1
약물 silicone C0037114
silicones
scispacy 1
약물 Poly Implant scispacy 1
질환 silicone granulomata scispacy 1
질환 lymphadenopathy C0497156
Lymphadenopathy
scispacy 1
질환 cutaneous abnormalities scispacy 1
기타 PIP → Poly Implant Prosthese, France scispacy 1
기타 patient scispacy 1

MeSH Terms

Adult; Breast Implants; Device Removal; Female; Granuloma, Foreign-Body; Humans; Lymphatic Diseases

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문